galeratx.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi GRTX

Is it worth investing in Galera Therapeutics (GRTX), whose radiation-induced stomatitis treatments rely on grants and investments? The EBITDA financial metric provides the answer, and the value of captures this indicator. Risks are increasing due to the complete outsourcing of testing and drug production to third-party contractors. Meanwhile, Galera Therapeutics is implementing software robots for data analysis and automating laboratory molecule screening.

GRTX: Bathi sadurunge mbayar bunga, pajak, lan amortisasi Galera 04.07.2022 - 15.11.2026

Galera Therapeutics, Inc. - rincian analitis lan metrik utama (GRTX)

- nilai pasar lan prakiraan target analis:

Rega bursa galeratx.com|GRTX - Target konsensus

- rincian nilai pasar emiten:

Nilai pasar Galera Therapeutics Inc.|GRTX - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Buku Saham Galera Therapeutics|GRTX - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku galeratx.com|GRTX - Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Total Utang marang Modal Galera Therapeutics|GRTX - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Galera|GRTX - Gunggung utang perusahaan|Rasio utang-utang marang kapitalisasi buku Galera Therapeutics Inc.|GRTX - Utang jangka dawa perusahaan|Utang jangka cendhak Galera Therapeutics|Rasio jangkoan perantara galeratx.com

- informasi bathi lan kelipatan valuasi:

GRTX - Bathi resik perusahaan|Bathi mangsa ngarep Galera Therapeutics|GRTX - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi Galera|GRTX - Pangali PEG|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Galera Therapeutics, Inc.|GRTX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Galera Therapeutics|GRTX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan galeratx.com|GRTX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Galera Therapeutics

- data dodolan lan asil:

GRTX - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Galera|GRTX - Multiplikator P/S|Multiplikator Forward P/S Galera

Ringkesan analitik perusahaan:Galera Therapeutics, Inc., GRTX

To stress-test long-term positions, it is critical for an investor to evaluate the actual cash flow from core operations before taxes and depreciation. Analyzing the level of net operating income before depreciation allows Galera Therapeutics (GRTX) to confirm the monetization of its radiation tissue protection drugs, transforming steady hospital demand into actual liquidity, which determines the fundamental stability of the business.

Pesaing Galera Therapeutics (GRTX)

Geron (GERN) - Bathi sadurunge bunga, pajak, lan amortisasi|NBTX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi BCYC (Bicycle Therapeutics PLC)|CytomX Therapeutics, Inc. (CTMX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi CATX (Perspective Therapeutics Inc)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Genelux Corporation|Bathi sadurunge mbayar bunga, pajak, lan amortisasi MOLN|Bathi operasional EBITDA ONCY|Bathi operasional EBITDA Lisata (LSTA)|Moleculin Biotech - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MTEM (Molecular Templates Corp)